Altamira Therapeutics Ltd. Adjustments For Decrease Increase In Other Operating Receivables
Altamira Therapeutics Ltd. (CYTOF) reported Adjustments For Decrease Increase In Other Operating Receivables of -$38.59 thousand for the 6-month period ending 2024-06-30, per its 6-K filed 2024-09-24.
Discontinued › Notes › Receivables
ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables · last filed 2024-09-24
CHF
| Period end | Adjustments For Decrease Increase In Other Operating Receivables 6 month | Adjustments For Decrease Increase In Other Operating Receivables 12 month | Adjustments For Decrease Increase In Other Operating Receivables 12 month as first filed |
|---|---|---|---|
| 2023-06-30 | -62.84K CHF 6-K · filed 2023-09-12 | ||
| 2022-12-31 | -103.60K CHF 20-F · filed 2023-05-16 | ||
| 2022-06-30 | 23.35K CHF 6-K · filed 2023-09-12 | ||
| 2021-12-31 | -340.12K CHF 20-F · filed 2023-05-16 | -586.61K CHF 20-F · filed 2022-04-12 | |
| 2021-06-30 | -59.45K CHF 6-K/A · filed 2023-08-21 | ||
| 2020-12-31 | 254.44K CHF 20-F · filed 2023-05-16 | ||
| 2020-06-30 | 184.28K CHF 6-K · filed 2021-09-08 | ||
| 2019-12-31 | -18.93K CHF 20-F · filed 2022-04-12 | ||
| 2019-06-30 | 19.07K CHF 6-K/A · filed 2020-09-17 | ||
| 2018-12-31 | -18.39K CHF 20-F · filed 2021-03-31 | ||
| 2018-06-30 | -124.41K CHF 6-K · filed 2019-08-15 | ||
| 2017-12-31 | 93.33K CHF 20-F · filed 2020-04-16 | ||
| 2016-12-31 | 277.48K CHF 20-F · filed 2019-03-14 | ||
| 2015-12-31 | -146.24K CHF 20-F · filed 2018-03-22 |
USD
| Period end | Adjustments For Decrease Increase In Other Operating Receivables 6 month |
|---|---|
| 2024-06-30 | -$38.59K 6-K · filed 2024-09-24 |
| 2023-06-30 | -$68.91K 6-K · filed 2024-09-24 |